Summary

Other Scenarios:

Buyer: The Procter & Gamble Company (PG) Last Price: 63.48 Market Cap.: 199.89B
Target: Cadbury Schweppes plc (ADR) (CSG) Last Price: 57.10 Market Cap.: 29.99B

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare   881
Biopharmaceuticals   339
Medical Devices   247
Nutritional Health   26
Scientific Products   39
*Media   146
Entertainment/Programming   40
Manufacturing 1,185
Consumer Manufacturing 337

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 75)
  • Millstone
  • Folgers
  • Iams
  • Eukanuba
Target (Total: 21)
  • Snapple
  • 7 Up
  • Canada Dry
  • Clamato
Buyer
  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
Target

n/a

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 62)
  • Alexion Pharmaceuticals, Inc. (ALXN)
  • Multi-Color Corp. (LABL)
  • Tredegar Corporation (TG)
  • Griffon Corporation (GFF)
Target (Total: 17)
  • Coca-Cola Enterprises Inc. (CCE)
  • Publicis Groupe S.A. (ADR) (PUB)
  • Rexam PLC (ADR) (REXMY)
  • Crown Holdings, Inc. (CCK)
Buyer (Total: 11)
  • Wal-Mart Stores, Inc. (WMT)
  • sanofi-aventis (ADR) (SNY)
  • Dollar General Corp. (DG)
  • Sally Beauty Holdings, Inc. (SBH)
Target (Total: 7)
  • Coca-Cola Enterprises Inc. (CCE)
  • Hansen Natural Corp. (HANS)
  • Burger King Holdings, Inc. (BKC)
  • PepsiAmericas, Inc. (PAS)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 138,000 67,011
Revenue Per Employee 543,343.7 237,571.2
Total Revenue 18,694.0 7,973.8
Total Expenses 15,048.0 7,079.2
Other Revenue 0.0 0.0
Cost of Revenue 9,057.0 6,912.3
SG&A Expense 5,991.0 0.0
Research & Development 0.0 0.0
Other Operating Expense 0.0 -37.8
Operating Income 3,646.0 894.6
Unusual Income 0.0 204.8
LT Debt to Capital 24.23 33.32
Fwd P/E 20.97 23.48
Fwd P/Rev 2.62 2.08
Book Value 65,053.0 7,331.7
Curr Portion of LTD/Cap Lease 12,168.0 43.7

Individual Company Summary

Focused

Buyer

Focused (): Manufacturing > Consumer Manufacturing > Personal Care and Cleaning Products

Target

Focused (): Manufacturing > Consumer Manufacturing > Food, Beverage and Agriculture > Food > Sweets/Snacks > Confectionery

Business Description

Buyer

The Procter & Gamble Company (P&G) is focused on providing branded consumer goods products. The Company is organized into three global business units: Beauty and Health; Household Care, and Gillette GBU. Its products are sold in over 180 countries around the world primarily through mass merchandisers, grocery stores, membership club stores and drug stores. The Company owns or has licenses under patents and registered trademarks, which are used in connection with its activity in all businesses. Some of these patents or licenses cover product formulation and processes used to manufacture its products. P&G created new categories with new brands, such as Febreze, Swiffer, Kandoo, Prilosec OTC and ThermaCare. In September 2006, the Company's Sure brand (an antiperspirant and deodorant brand) was acquired by Innovative Brands, LLC. In January 2007, P&G acquired HDS Cosmetics Lab Inc., which manufactures and markets Doctor's Dermatologic Formula (DDF) skin care.

Target

Cadbury Schweppes plc is a confectionery company. The Company?s products include brands, such as such as Cadbury, Schweppes, Halls, Trident, Dr Pepper, Snapple, Trebor, Dentyne, Bubblicious and Bassett. Cadbury Schweppes operates in four segments: Americas Beverages, Americas Confectionery, Europe Middle East and Africa (EMEA) and Asia Pacific. In February 2006, the Company increased its stake from 46% to just over 50.02% in Cadbury Nigeria. On May 2, 2006, Cadbury Schweppes acquired the 55% of Dr Pepper/Seven-Up Bottling Group, which was not previously owned. During the year ended December 31, 2006, the Company acquired All American Bottling Company and Seven Up Bottling Company of San Francisco. In August 2006, Cadbury Schweppes sold Bromor Foods (Pty) Limited. In 2006, the Company disposed of its beverage operations in Europe, South Africa and Syria. On June 1, 2006, Cadbury Schweppes completed the acquisition of the chewing gum business from Dan Products (Botswana) (Pty) Ltd.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 51.89 13.49
Operating Margin % 19.99 12.24
Quick Ratio 0.36 0.49
Current Ratio 0.73 0.71
Coverage Ratio -0.09 -0.19
Total Assets 135,695.0 20,343.1
Return on Equity % 15 14.18
Return on Assets % 7.35 5.11
Cash+ ST Inv. Per Share 1.25 1.7
Total Debt 33,425.0 6,568.3
Total Debt to Equity % 50.29 89.59
Total Debt to Tangible Equity % n/a n/a
Debt to Asset % 24.63 32.29

Product Summary

Sector Buyer Target
*Healthcare  
Biopharmaceuticals  
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
  
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
  
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
  
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
  
Obstetrics/Gynecology
The Obstetrics/Gynecology Subsector includes therapeutics that treat female genital disorders, pregnancy, and childbirth.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Medical Devices  
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
  
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
  
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Scientific Products  
Consumables
The Consumables Subsector includes chemicals, reagents, standards, media, and disposable labware that are normally depleted or worn out by continuous use.
  
*Media  
Entertainment/Programming  
Television, Film and Video
Companies involved in the production, post-production, and distribution of Motion Pictures and Television programming.
  
Manufacturing
Consumer Manufacturing
Food, Beverage and Agriculture
Includes agricultural inputs like livestock and crops, as well as processed food and beverage products. Tobacco growers and cigarette manufacturers are also included.
Household Products
The Household Products sector includes furniture and other home and institutional decorative items, major and small appliances, kitchenware, and other related products.
  
Personal Care and Cleaning Products
Companies engaged in the manufacturing of personal care products, such as cosmetics, fragrances, skin lotion, shampoo and other toiletries; and household cleaning products, such as window/surface cleaner, and table polish.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare  
Biopharmaceuticals  
Allergies  
Upper Respiratory  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat allergic reactions by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.

Buyer Products:

  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
  
Cardiovascular System  
Heart Disorders  
Arrhythmia  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Buyer Products:

  • Azimilide
  
Dermatology  
Acne  
Vulgaris  
Retinoids/Vitamin A Analogs
Therapeutics that treat acne by helping in cell differentiation as well as prevent cell proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Lesion/Scaling Disorders  
Psoriasis  
Retinoids/Vitamin A Analogs
Therapeutics that treat a chronic autoimmune disease characterized by softening, separating, and causing the shedding of the horny layer of the skin by modulating cell differentiation and proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroduodenal Disorders  
Peptic Ulcers  
Duodenal  
Antisecretory Agents/Nitroimidazoles/Tetracyclines
Therapeutics that treat peptic ulcers by preventing the secretion of acid as well as treating infections by using antibiotics.

Buyer Products:

  • Helidac (Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride)
  
Gastroesophageal Disorders  
Acid Indigestion/Heartburn  
Proton Pump Inhibitors
Therapeutics that treat heartburn by inhibiting the action of the membrane protein involved in the final steps of triggering acid release into the stomach.

Buyer Products:

  • Prilosec OTC (Omeprazole)
  
Intestinal Disorders  
Constipation  
Chronic  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Metamucil (Psyllium)
  
Irregular Bowel Movements  
Bulk-Forming Agents
Therapeutics that treat constipation by stimulating the formation of bodies of feces that are able to be passed through the bowels.

Buyer Products:

  • Metamucil (Psyllium)
  
Diarrhea  
Antisecretory Agents
Therapeutics that treat diarrhea by bringing fluid movement within the intestine to normal levels.

Buyer Products:

  • Pepto Bismol (Bismuth Subsalicylate)
  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat ulcerative colitis by inhibiting the actions of the two enzymes, cyclooxygenase and lipoxygenase.

Buyer Products:

  • Asacol (Mesalamine)
  
Immunology  
Autoimmune Disorders  
Inflammatory Bowel Disease (IBD)  
Ulcerative Colitis  
Cyclooxygenase Inhibitors (COX Inhibitors)/Lipoxygenase Inhibitors
Therapeutics that treat inflammation of the colon and rectum by blocking the action of cyclooxygenase and lipoxygenase.

Buyer Products:

  • Asacol (Mesalamine)
  
Psoriasis  
Retinoids/Vitamin A Analogs
Therapeutics that treat a chronic autoimmune disease characterized by softening, separating, and causing the shedding of the horny layer of the skin by modulating cell differentiation and proliferation.

Buyer Products:

  • Tazorac (Tazarotene)
  
Infectious Diseases  
Bacterial  
Antibacterial Agents  
Narrow Spectrum  
Digestive System  
Heliobacter pylori  
Antisecretory Agents/Nitroimidazoles/Tetracyclines
Therapeutics treat digestive infections caused by Helicobacter pylori bacteria by inhibiting the action of the membrane protein involved in the final steps of triggering acid release into the stomach.

Buyer Products:

  • Helidac (Bismuth Subsalicylate/Metronidazole/Tetracycline Hydrochloride)
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Nitrofurantoins
Therapeutics that treat bacterial infections of the urinary tract by inactivating/altering bacterial proteins and other macromolecules.

Buyer Products:

  • Macrobid (Nitrofurantoin)
  • Macrodantin (Nitrofurantoin)
  
Musculoskeletal System  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of skeletal system disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Parathyroid Hormone (PTH 1-34) Nasal Spray
  
Skeletal Disorders  
Bone Disorders  
Heterotopic Ossification  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat ossification by inhibiting the loss of bone material by osteoclasts.

Buyer Products:

  • Didronel (Etidronate Disodium)
  
Osteoporosis  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat osteoporosis by preventing loss of bone mass due to osteoclasts.

Buyer Products:

  • Actonel (Risedronate Sodium)/Once Weekly Actonel (Risedronate Sodium)/Actonel With Calcium
  
Paget`s Disease  
Osteoclast Bone Resorption Inhibitors
Therapeutics that treat paget's disease by inhibiting the loss of bone material by osteoclasts.

Buyer Products:

  • Actonel (Risedronate Sodium)/Once Weekly Actonel (Risedronate Sodium)/Actonel With Calcium
  • Didronel (Etidronate Disodium)
  
Neurology  
Neurological Disorders  
Spasticity (Spinal Shock)  
Calcium Channel Inhibitors
Therapeutics that treat spasticity by preventing the release of calcium from the sarcoplasmic reticulum which results in reduced involuntary muscle contractions.

Buyer Products:

  • Dantrium/Dantrium I.V. (Dantrolene Sodium)
  
Obstetrics/Gynecology  
Female Genital Disorders  
Sexual Dysfunction  
Androgens
Therapeutics that treat female sexual dysfunction by providing male sex hormone, such as testosterone, that is important for the normal functioning of the female reproductive system.

Buyer Products:

  • Intrinsa (Testosterone Patch)
  
Respiratory System  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Amphetamines
Therapeutics that treat coughs and colds by helping to relieve nasal congestion.

Buyer Products:

  • Vicks Vapor Inhaler (1-Desoxyephedrine)
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Vicks NyQuil Cough (Doxylamine Succinate/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, and relieving or preventing coughs.

Buyer Products:

  • Vicks Children's NyQuil (Chlorpheniramine Maleate/Pseudoephedrine HCl/Dextromethorphan HBr)
  • Vicks Pediatric Formula 44M Multi Symptom Cough & Cold (Chlorpheniramine Maleate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Antihistamines/Decongestants/Antitussives/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by suppressing inflammation, reducing mucous build up, relieving or preventing coughs, relieving pain, and reducing fever.

Buyer Products:

  • Vicks NyQuil Multi Symptom Cold/Flu Relief (Doxylamine Succinate/Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Acetaminophen)
  • Vicks 44M Cough, Cold & Flu Relief (Chlorpheniramine Maleate/Dextromethorphan Hydrobromide/Pseudoephedrine Hydrochloride/Acetaminophen)
  
Antitussives
Therapeutics that relieve or prevent coughs.

Buyer Products:

  • Vicks 44 Cough Relief (Dextromethorphan Hydrobromide)
  
Antitussives/Expectorants
Therapeutics that treat coughs and colds by suppressing coughs and helping ejection of the mucous.

Buyer Products:

  • Vicks 44E/Vicks Pediatric Formula 44E (Dextromethorphan HBr/Guaifenesin)
  
Decongestants
Therapeutics that treat coughs and colds by reducing mucous build up.

Buyer Products:

  • Vicks Inhaler (Levmetamfetamine)
  • Vicks Sinex (Phenylephrine Hydrochloride)
  • Vicks Sinex 12 Hour (Oxymetazoline)
  
Decongestants/Antitussives
Therapeutics that treat coughs and colds by reducing mucous build up and suppressing the cough.

Buyer Products:

  • Vicks 44D Cough & Head Congestion Relief (Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide)
  
Decongestants/Antitussives/Expectorants/Analgesics/Antipyretics
Therapeutics that treat coughs and colds by reducing mucous build up, suppressing the cough, helping in the ejection of mucous and helping relieve fever and pain.

Buyer Products:

  • Vicks DayQuil Multi Symptom Cold/Flu Relief (Pseudoephedrine Hydrochloride/Dextromethorphan Hydrobromide/Guaifenesin/Acetaminophen)
  
Decongestants/Expectorants
Therapeutics that treat coughs and colds by reducing mucous build up and help in ejection of mucous.

Buyer Products:

  • Vicks DayQuil Sinus Presure & Pain Relief (Phenylpropanolamine/Guaifenesin)
  
Expectorants/Opioids
Therapeutics that treat coughs and colds by suppressing the cough and helping in the ejection of the mucous.

Buyer Products:

  • Brontex (Guaifenesin/Codeine Phosphate)
  
Surgery  
General  
Complications  
Hyperthermia  
Calcium Channel Inhibitors
Therapeutics that treat hyperthermia by preventing the release of calcium from the sarcoplasmic reticulum which results in inhibits the catabolic processes responsible for increase in temperature.

Buyer Products:

  • Dantrium/Dantrium I.V. (Dantrolene Sodium)
  
Urology  
Urological Disorders  
Bladder  
Urinary Frequency/Urge Incontinence  
Anticholinergic Agents
Therapeutics that treat the inability to control urinary excretory functions by blocking the actions of choline and other cholinergic agents.

Buyer Products:

  • Enablex (Darifenacin)
  
Medical Devices  
Medical Supplies  
Diagnostic  
Temperature  
Thermometers
Medical instruments designed to measure the temperature in patients

Buyer Products:

  • Vicks Thermometer Series
  
Orthopedics  
Treatment  
Pain Management  
General Purpose  
Dry Heat Therapy
Devices that control the of use dry heat to ease pain associated with musculoskeletal injuries.

Buyer Products:

  • ThermaCare Heatwrap Series
  
Nutritional Health  
Dietary/Naturopathic Supplements  
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • The Procter & Gamble Company
  
Scientific Products  
Consumables  
Bioanalytical Chemistry  
Cell Biology  
Cell Proliferation  
Kits
Cell proliferation consumables that are a collection of reagents, standards, and other consumables assembled for used in various biological analyses.

Buyer Products:

  • E-Cube Culture System Kit
  • CellCube System
  
*Media  
Entertainment/Programming  
Television, Film and Video  
Production  
Television  
Domestic  
Soap Opera
Shows depicting the interconnected lives of many characters often in a sentimental, melodramatic way.

Buyer Products:

  • Procter & Gamble Productions
  
Manufacturing
Consumer Manufacturing
Food, Beverage and Agriculture
Beverages
Non-Alcoholic Beverages
Coffee/Tea
Coffee and Tea Manufacturing.

Buyer Products:

  • Millstone
  • Folgers
  
Juice/Soft Drink
Companies which manufacture soda, energy drinks, and fruit juice.

Target Products:

  • Snapple
  • 7 Up
  • Canada Dry
  • Clamato
  • Schweppes
  • Hawaiian Punch
  • Mott's
  • Orangina
  • Dr. Pepper
  
Food
Pet Food
Food for dogs and cats.

Buyer Products:

  • Iams
  • Eukanuba
  
Sweets/Snacks
Confectionery  
Chocolate and Chocolate Confectionery
Chocolate and chocolate confectionery manufacturing.

Target Products:

  • Cadbury
  
Non-chocolate Confectionery
Non-chocolate based confectionery manufacturing.

Target Products:

  • Bassett's
  • Trebor
  • Trident
  • Bubbas
  • Dentyne Ice
  • Halls
  • Hollywood
  • Maynards
  • Sour Patch Kids
  • Stimorol
  
Snack Foods
Manufacturers of Potato Chips, Peanuts, Trail Mix, and Cheese Snacks.

Buyer Products:

  • Pringles

Target Products:

  • Butterkist
Household Products  
Household Appliances and Tools  
Other Household Products  
Brooms, Brushes, and Mops
Brooms, brushes, mops, and other manual cleaning equipment.

Buyer Products:

  • Swiffer
  
Small Electrical Appliances/Accessories  
Consumer Batteries
Relatively small, portable batteries used to power all varieties of consumer electronic devices. These one-time-use or rechargeable batteries store electric energy and can be used to power various devices ranging from CD players to cell phones. The most popular battery types include: lithium (Li), lithium ion (Li-ion), nickel-metal hybrid (NiMH), and nickel-cadmium (NiCAD). Flashlights are included at this level.

Buyer Products:

  • Duracell
  
Kitchen/Bath Appliances
Electrical Kitchen/Bath Appliances, including toasters; juicemakers; and food blenders, as well as electrical toothbrushes, hairdryers, and electric massagers.

Buyer Products:

  • Oral-B
  
Personal Care and Cleaning Products  
Absorbent Products
Absorbent products, including tampons, pads, and diapers.

Buyer Products:

  • Tampax
  • Pampers
  • Always
  
Anti-Perspirant
Anti-Perspirant and/or deodorant.

Buyer Products:

  • Old Spice
  • Secret
  
Cosmetics
Companies engaged in the manufacturing of cosmetics, such as lipstick, powders, and other make-up.

Buyer Products:

  • CoverGirl
  • Max Factor
  • Olay
  
Fragrances
Companies engaged in the manufacturing of fragrances, such as perfume and cologne.

Buyer Products:

  • Hugo Boss
  • Giorgio Beverly Hills
  
Hair Care
Companies engaged in the manufacturing of hair care products, such as shampoo, conditioner, hair dye, hair spray, styling gel, and mousse. Also includes hair accessories, such as pins, clips, and curlers.

Buyer Products:

  • Pantene
  • Physique
  • Clairol
  • Herbal Essences
  • Infusium 23
  • Aussie
  • Head & Shoulders
  
Household Cleaning Products
Chemical-based household cleaning products, such as detergent and surface cleaner. Also includes automotive cleaning products.

Buyer Products:

  • Downy
  • Tide
  • Mr. Clean
  • Swiffer
  • Febreze
  
Oral Care
Oral Care products, including Toothpaste, Mouthwash, and denture adhesive.

Buyer Products:

  • Fixodent
  
Sanitary/Personal Care Paper
Companies engaged in the manufacturing of sanitary/personal care paper such as napkins and tissues.

Buyer Products:

  • Puffs
  • Charmin
  • Bounty
  
Skin Care
Companies engaged in the manufacturing of skin care products, such as suntan lotion, skin lotion, sanitizer, shaving cream, and moisturizer. Also includes manufacturers of non-electrical shaving equipment.

Buyer Products:

  • Gillette
  • Doctor's Dermatologic Formula
  • Noxzema
  • Olay
  
Soap/Body Wash
Soap, Body Wash, and Shower Gel.

Buyer Products:

  • Camay
  • Safeguard
  • Ivory
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  PepsiCo, Inc. n/a 111,907.004 19.60 20.52 3.17 2.92 11.73
Diageo plc (ADR) n/a 57,730.642 20.83 18.60 4.00 2.98 n/a
Unilever plc (ADR) n/a 50,944.287 7.53 16.73 0.96 0.95 n/a
Unilever N.V. (ADR) n/a 49,233.535 7.69 16.20 0.92 0.77 n/a
Buyer
  GlaxoSmithKline plc (ADR) n/a 146,595.267 13.74 13.24 3.23 3.24 14.01
PepsiCo, Inc. n/a 111,907.004 19.60 20.52 3.17 2.92 11.73
Target
  The Procter & Gamble Company n/a 199,893.680 20.37 20.97 2.66 2.62 n/a
The Coca-Cola Company n/a 121,961.136 23.29 20.38 4.89 4.56 10.88
PepsiCo, Inc. n/a 111,907.004 19.60 20.52 3.17 2.92 11.73
Diageo plc (ADR) n/a 57,730.642 20.83 18.60 4.00 2.98 n/a
Kraft Foods Inc. n/a 55,213.531 20.03 18.80 1.59 1.52 n/a
Unilever plc (ADR) n/a 50,944.287 7.53 16.73 0.96 0.95 n/a
Unilever N.V. (ADR) n/a 49,233.535 7.69 16.20 0.92 0.77 n/a
Groupe Danone (ADR) n/a 38,177.047 21.10 21.25 2.03 1.81 52.77
Colgate-Palmolive Company n/a 34,479.649 23.19 20.23 2.74 2.57 n/a
Kellogg Company n/a 21,598.386 20.55 19.42 1.94 1.86 n/a
General Mills, Inc. n/a 21,245.925 18.60 19.38 1.74 1.72 n/a
Wm. Wrigley Jr. Company n/a 15,998.523 28.56 26.16 3.29 3.09 29.30
H.J. Heinz Company n/a 15,625.256 19.89 18.44 1.74 1.68 n/a
Campbell Soup Company n/a 15,518.057 18.54 20.15 2.01 1.99 n/a
Sara Lee Corp. n/a 13,310.611 33.70 22.37 1.01 1.07 n/a
ConAgra Foods, Inc. n/a 12,955.315 20.80 18.75 1.11 1.10 30.16
The Hershey Company n/a 12,123.400 22.87 21.78 2.45 2.37 n/a
Coca-Cola Enterprises Inc. n/a 11,181.885 n/a 18.98 0.56 0.54 n/a
Coca-Cola Femsa SAB de CV (ADR) n/a 7,467.367 16.43 14.94 1.50 1.35 2.18

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Publicis Groupe S.A. (ADR) 10.00% 8,381.518 13.95 16.27 1.41 1.28 n/a
Crown Holdings, Inc. n/a 4,128.605 12.98 18.20 0.58 0.55 n/a
Silgan Holdings Inc. n/a 2,211.876 19.18 17.60 0.80 0.74 64.68
I-Many, Inc. n/a 112.211 n/a n/a 3.70 n/a n/a
Buyer
  Alexion Pharmaceuticals, Inc. 37.70% 1,792.090 n/a -13.53 252.14 45.02 20.14
Multi-Color Corp. 30.00% 263.542 23.90 20.02 1.19 n/a n/a
Tredegar Corporation 23.40% 936.366 23.22 19.58 0.83 n/a 2.38
Griffon Corporation 14.00% 699.081 15.03 20.30 0.40 n/a 2.17
Target
  Coca-Cola Enterprises Inc. n/a 11,181.885 n/a 18.98 0.56 0.54 n/a
Publicis Groupe S.A. (ADR) n/a 8,381.518 13.95 16.27 1.41 1.28 n/a
Rexam PLC (ADR) n/a 6,257.189 14.18 14.74 0.85 0.85 n/a
Crown Holdings, Inc. n/a 4,128.605 12.98 18.20 0.58 0.55 n/a
Hansen Natural Corp. n/a 3,631.184 38.55 27.26 6.57 4.29 20.10
Silgan Holdings Inc. n/a 2,211.876 19.18 17.60 0.80 0.74 64.68
W. P. Carey & Co. LLC n/a 1,298.354 15.09 18.32 4.79 n/a 2.48
Capital Lease Funding, Inc. n/a 492.821 184.46 10.34 3.74 3.04 1.64
Senomyx Inc. n/a 412.754 n/a -15.17 32.03 25.30 6.26
Packeteer, Inc. n/a 377.389 n/a -54.00 2.56 2.25 4.08
Chesapeake Corporation n/a 264.752 n/a 53.48 0.26 0.26 n/a
Applix, Inc. n/a 252.720 25.29 38.88 4.43 3.66 11.86
Saba Software, Inc. n/a 175.449 n/a 46.23 1.80 1.69 n/a
I-Many, Inc. n/a 112.211 n/a n/a 3.70 n/a n/a
Inforte Corp. n/a 48.929 n/a n/a 1.13 n/a 1.39
Conversion Services International Inc. n/a 17.999 n/a n/a 0.74 n/a n/a
Verticalnet, Inc. n/a 3.529 n/a n/a 0.22 n/a n/a

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Wal-Mart Stores, Inc. 15.00% 203,898.929 17.74 15.06 0.57 0.52 4.48
sanofi-aventis (ADR) n/a 130,750.407 23.90 13.66 3.25 3.40 n/a
Dollar General Corp. n/a 6,790.483 49.23 32.30 0.74 0.72 3.89
Sally Beauty Holdings, Inc. n/a 1,649.946 27.78 28.66 0.67 0.66 n/a
Tween Brands Inc. n/a 1,337.599 20.39 19.61 1.47 1.31 4.09
99 Cents Only Stores n/a 993.704 157.40 52.00 1.22 0.81 1.92
Prestige Brands Holdings, Inc. n/a 666.567 18.47 17.53 2.09 1.96 n/a
Fred's, Inc. n/a 576.967 21.57 17.98 0.33 0.31 1.56
United-Guardian, Inc. n/a 65.822 20.10 n/a 4.85 n/a 4.57
AMCON Distributing Co. n/a 13.214 12.89 n/a 0.02 n/a n/a
Synergy Brands Inc. n/a 6.327 n/a n/a 0.09 n/a 1.31
Target
  Coca-Cola Enterprises Inc. n/a 11,181.885 n/a 18.98 0.56 0.54 n/a
Hansen Natural Corp. n/a 3,631.184 38.55 27.26 6.57 4.29 20.10
Burger King Holdings, Inc. n/a 3,535.517 34.66 23.49 1.62 1.55 n/a
PepsiAmericas, Inc. n/a 3,164.887 19.20 17.59 0.77 0.74 n/a
Compania Cervecerias Unidas S.A. (ADR) n/a 2,260.733 24.54 17.89 2.40 n/a 3.53
J&J Snack Foods Corp. n/a 743.741 23.65 21.61 1.38 1.27 4.82
Coca-Cola Bottling Co. Consolidated n/a 504.520 18.63 n/a 0.35 n/a n/a

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Berkshire Hathaway Inc. n/a 168,582.644 14.92 n/a 1.55 n/a 2.18
sanofi-aventis (ADR) n/a 130,750.407 23.90 13.66 3.25 3.40 n/a
The Clorox Company n/a 10,158.862 21.21 20.60 2.11 2.08 n/a
Dollar General Corp. n/a 6,790.483 49.23 32.30 0.74 0.72 3.89
Invitrogen Corporation n/a 3,388.555 n/a 20.82 2.68 2.79 n/a
Wesco Financial Corporation n/a 3,025.919 33.18 n/a 5.02 n/a 1.41
Inverness Medical Innovations, Inc. n/a 2,243.992 n/a 38.77 3.74 3.41 8.13
Alexion Pharmaceuticals, Inc. n/a 1,792.090 n/a -13.53 252.14 45.02 20.14
Regis Corporation n/a 1,772.147 18.31 18.72 0.68 0.67 n/a
Sally Beauty Holdings, Inc. n/a 1,649.946 27.78 28.66 0.67 0.66 n/a
Arbitron Inc. n/a 1,575.575 32.85 36.36 4.69 4.45 24.02
Regeneron Pharmaceuticals, Inc. n/a 1,516.401 n/a -13.36 24.85 18.56 7.71
Macrovision Corporation n/a 1,491.824 41.12 27.95 5.83 5.15 4.86
Target
  PepsiCo, Inc. n/a 111,907.004 19.60 20.52 3.17 2.92 11.73
The Hershey Company n/a 12,123.400 22.87 21.78 2.45 2.37 n/a
Coca-Cola Enterprises Inc. n/a 11,181.885 n/a 18.98 0.56 0.54 n/a
The Pepsi Bottling Group, Inc. n/a 7,954.875 15.39 17.76 0.62 0.59 n/a
Hansen Natural Corp. n/a 3,631.184 38.55 27.26 6.57 4.29 20.10
Burger King Holdings, Inc. n/a 3,535.517 34.66 23.49 1.62 1.55 n/a
PepsiAmericas, Inc. n/a 3,164.887 19.20 17.59 0.77 0.74 n/a
Compania Cervecerias Unidas S.A. (ADR) n/a 2,260.733 24.54 17.89 2.40 n/a 3.53
J&J Snack Foods Corp. n/a 743.741 23.65 21.61 1.38 1.27 4.82
Coca-Cola Bottling Co. Consolidated n/a 504.520 18.63 n/a 0.35 n/a n/a
Senomyx Inc. n/a 412.754 n/a -15.17 32.03 25.30 6.26
Red Bull GmbH n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 75,046.0 14,764.8 89,810.8
Other Revenue 0.0 0.0 0.0
Total Revenue 75,046.0 14,764.8 89,810.8
Cost of Revenue 36,103.0 12,772.9 48,875.9
SG&A Expense 23,944.0 0.0 23,944.0
Depreciation & Amortization 0.0 6.0 6.0
Interest Expense 0.0 0.0 0.0
Other Operating Expense 0.0 -85.5 -85.5
Unusual Expense (Income) 0.0 264.4 264.4
Total Expenses 60,047.0 12,957.7 73,004.7
Operating Income 14,999.0 1,807.1 16,806.1
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng -1,276.0 -339.9 -1,615.9
Other, Net 490.0 0.0 490.0
Income Before Taxes 14,213.0 1,467.1 15,680.1
Income Taxes 4,243.0 427.4 4,670.4
Income After Taxes 9,970.0 1,039.7 11,009.7
Minority Interest (IS) 0.0 8.0 8.0
Net Income - Excl. Xord. Items 9,970.0 1,047.7 11,017.7
Discontinued Operations 0.0 1,276.3 1,276.3
Net Income - Incl. Xord. Items 9,970.0 2,324.0 12,294.0
Preferred Dividends -157.0 0.0 -157.0
Income Avail. to Common 9,813.0 2,324.0 12,137.0
Share Items
Basic Avg. Shares Outstanding 3,397.3 519.0 3,916.3
Basic EPS - Excl. Xord. Items 2.89 2.02 2.81
Basic EPS - Incl. Xord. Items 2.89 4.48 3.14
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 3,397.3 522.8 3,920.0
F.D. EPS - Excl. Xord. Items 2.89 2.00 2.81
F.D. EPS - Incl. Xord. Items 2.89 4.45 3.14
Dividends Per Common Share 1.24 1.11 2.35
Balance Sheet
Assets
Cash and Equivalents 3,994.0 534.8 4,528.8
ST Investments 236.0 351.9 587.9
Accounts Receivable 6,757.0 2,429.3 9,186.3
Inventory 7,091.0 1,447.3 8,538.3
Prepayments and Advances 2,938.0 0.0 2,938.0
Other Current Assets 1,698.0 0.0 1,698.0
Current Assets 22,714.0 4,763.2 27,477.2
PPE 34,132.0 0.0 34,132.0
Accum D&A -14,954.0 0.0 -14,954.0
PPE, Net 19,178.0 3,308.0 22,486.0
Goodwill & Intangibles 89,934.0 11,735.1 101,669.1
Long Term Investments 0.0 47.7 47.7
Note Receivable 0.0 107.4 107.4
Other Assets 0.0 0.0 0.0
Other LT Assets 3,869.0 381.7 4,250.7
Total Assets 135,695.0 20,343.1 156,038.1
Liabilities
Accounts Payable 4,371.0 3,156.9 7,527.9
Payable/Accrued 0.0 0.0 0.0
Accrued Expenses 10,777.0 0.0 10,777.0
ST Debt 0.0 2,860.7 2,860.7
Curr Port of LTD & Cap Lease Oblg 12,168.0 43.7 12,211.7
Other (Current) Liabilities 3,605.0 654.0 4,259.0
Current Liab. 30,921.0 6,715.4 37,636.4
LT Debt 21,257.0 3,598.3 24,855.3
Capitalized Lease Obligations 0.0 65.6 65.6
Total LT Debt 21,257.0 3,663.9 24,920.9
Minority Interest (BS) 0.0 15.9 15.9
Deferred Taxes 12,272.0 2,087.4 14,359.4
Other LT Liab. 4,779.0 528.8 5,307.8
Total Liabilities 69,229.0 13,011.4 82,240.4
Shareholders Equity
Redeemable Preferred 1,413.0 0.0 1,413.0
Common Stock 3,987.0 520.9 4,507.9
Additional Paid in Capital 58,912.0 2,327.9 61,239.9
Retained Earnings 40,477.0 4,482.9 44,959.9
Treasure Stock -37,405.0 0.0 -37,405.0
Other Equity 386.0 0.0 386.0
ESOP Debt Guarantee -1,304.0 0.0 -1,304.0
Total Equity 66,466.0 7,331.7 73,797.7
Total Liab. & Equity 135,695.0 20,343.1 156,038.1
Shares Outstanding 3,148.9 523.8 3,672.7
Cash Flow
Operating Cash Flow
CF Net Income 9,970.0 1,039.7 11,009.7
CF Depreciation 3,103.0 536.8 3,639.8
CF Deferred Taxes 78.0 0.0 78.0
Other Non-Cash Items 575.0 1,986.0 2,561.0
Change in Working Capital -683.0 -2,329.9 -3,012.9
Total Cash From Operating Activities 13,043.0 1,232.6 14,275.6
Investing Cash Flow (not calculated)
Capital Expenditures -2,997.0 -763.4 -3,760.4
Other Investing Cash Flows 1,693.0 1,801.1 3,494.1
Total Cash From Investing Activities -1,304.0 1,037.7 -266.3
Financing Cash Flow (not calculated)
Dividends Paid -4,127.0 -540.7 -4,667.7
Purchase Or Sale of Stock -8,882.0 -8.0 -8,890.0
Purchase and Retirement of Debt -3,735.0 -1,928.4 -5,663.4
Other Financing Cash Flow 0.0 -8.0 -8.0
Total Cash From Financing Activities -16,744.0 -2,409.4 -19,153.4
Exchange Rate Effects 324.0 -39.8 284.2
Net Change in Cash -4,681.0 -178.9 -4,859.9
Cash Taxes Paid 2,869.0 673.9 3,542.9
Cash Interest Paid 1,045.0 425.4 1,470.4